Skip to content

DRUGS MADE IN AMERICA ACQ II CORP

US · DMII #3572 by market cap
10.23 -0.02 -0.20%
Periodic snapshot; not a real-time feed. · 2026-11-20 16:04

Revenue annual, last 2 years

Income statement

Line item 2024 2025
Revenue ----
Gross profit ----
Selling & admin expenses --488.39K
Research & development ----
Operating profit ---1.30M
Pretax profit --4.19M
Tax ----
Net profit --4.19M
Basic EPS --0
Diluted EPS --0.15

Balance sheet

Line item 2024 2025
Total current assets 59.62K26.04K
Cash & ST investments 17.04K223
Inventory ----
Total assets 138.06K504.96M
Total current liabilities 254.78K300.86K
Short-term debt 250.10K--
Long-term debt ----
Total liabilities 254,783.0017,800,864.00
Total equity -116.72K487.16M
Retained earnings -151.72K-17.78M

Cash flow

Line item 2024 2025
Operating cash flow ---1.02M
Depreciation & amortization ----
Free cash flow ---1.02M
Dividends paid ----
Stock buybacks / issuance --502.00M
Ending cash balance --223

Returns & efficiency

Quote time 2026-11-20 16:04:04 · For reference only, not investment advice and not tailored to your situation.

DRUGS MADE IN AMERICA ACQ II CORP discussion 0 comments

Add a comment